MedCity News August 19, 2024
Cresilon snagged its second FDA clearance for human use. The FDA granted 510(k) clearance to Traumagel, the startup’s gel that can stop bleeding in just seconds, for temporary external use to control moderate to severe bleeding.
Some of the world’s most impactful companies were founded by college-aged visionaries — think Facebook, Microsoft and Dell. While it is unlikely that Brooklyn-based Cresilon will achieve levels of size and influence as grand as these aforementioned tech giants, the startup has come an impressively long way since being founded in 2010 by Joe Landolina, who was a first-year student at New York University at the time.
Cresilon has raised about $130 million in venture capital dollars and grown to comprise more than 80...
Today's Sponsors
Today's Sponsor